Fora Capital, LLC Pacira Bio Sciences, Inc. Transaction History

Fora Capital, LLC

$789 Million
Q3 2024

A detailed history of Fora Capital, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 28,614 shares of PCRX stock, worth $474,992. This represents 0.05% of its overall portfolio holdings.

Number of Shares

28,614

Holding current value

$474,992

% of portfolio

0.05%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$11.7 - $28.46 $334,783 - $814,354	28,614 New	28,614 $430,000
Q2 2022 Aug 11, 2022	SELL	$51.49 - $81.64 $418,665 - $663,814	-8,131 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$60.03 - $76.49 $488,103 - $621,940	8,131 New	8,131 $615,000
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $17,021 - $22,621	-287 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$50.47 - $66.26 $6,914 - $9,077	-137 Reduced 32.31%	287 $17,000
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $635,541 - $770,427	-12,229 Reduced 96.65%	424 $25 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $342,865 - $584,096	11,132 Added 731.89%	12,653 $664 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $132,400 - $236,363	-4,662 Reduced 75.4%	1,521 $50,000
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $224,504 - $289,549	6,183 New	6,183 $280,000

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$133 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$88 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$82.4 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$33.4 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$32.9 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $761M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Account